Cargando…
Co-production of farnesol and coenzyme Q(10) from metabolically engineered Rhodobacter sphaeroides
BACKGROUND: Farnesol is an acyclic sesquiterpene alcohol present in the essential oils of various plants in nature. It has been reported to be valuable in medical applications, such as alleviation of allergic asthma, gliosis, and edema as well as anti-cancerous and anti-inflammatory effects. Coenzym...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6544981/ https://www.ncbi.nlm.nih.gov/pubmed/31151455 http://dx.doi.org/10.1186/s12934-019-1145-6 |
_version_ | 1783423326966775808 |
---|---|
author | Chen, Xueduan Jiang, Xianzhang Xu, Man Zhang, Mingliang Huang, Runye Huang, Jianzhong Qi, Feng |
author_facet | Chen, Xueduan Jiang, Xianzhang Xu, Man Zhang, Mingliang Huang, Runye Huang, Jianzhong Qi, Feng |
author_sort | Chen, Xueduan |
collection | PubMed |
description | BACKGROUND: Farnesol is an acyclic sesquiterpene alcohol present in the essential oils of various plants in nature. It has been reported to be valuable in medical applications, such as alleviation of allergic asthma, gliosis, and edema as well as anti-cancerous and anti-inflammatory effects. Coenzyme Q(10) (CoQ(10)), an essential cofactor in the aerobic respiratory electron transport chain, has attracted growing interest owing to its clinical benefits and important applications in the pharmaceutical, food, and health industries. In this work, co-production of (E,E)-farnesol (FOH) and CoQ(10) was achieved by combining 3 different exogenous terpenes or sesquiterpene synthase with the RNA interference of psy (responsible for phytoene synthesis in Rhodobacter sphaeroides GY-2). RESULTS: FOH production was significantly increased by overexpressing exogenous terpene synthase (TPS), phosphatidylglycerophosphatase B (PgpB), and sesquiterpene synthase (ATPS), as well as RNAi-mediated silencing of psy coding phytoene synthase (PSY) in R. sphaeroides strains. Rs-TPS, Rs-ATPS, and Rs-PgpB respectively produced 68.2%, 43.4%, and 21.9% higher FOH titers than that of the control strain. Interestingly, the CoQ(10) production of these 3 recombinant R. sphaeroides strains was exactly opposite to that of FOH. However, CoQ(10) production was almost unaffected in R. sphaeroides strains modified by psy RNA interference. The highest FOH production of 40.45 mg/L, which was twice as high as that of the control, was obtained from the TPS-PSYi strain, where the exogenous TPS was combined with the weakening of the phytoene synthesis pathway via psy RNA interference. CoQ(10) production in TPS-PSYi, ATPS-PSYi, and PgpB-PSYi was decreased and lower than that of the control strain. CONCLUSIONS: The original flux that contributed to phytoene synthesis was effectively redirected to provide precursors toward FOH or CoQ(10) synthesis via psy RNA interference, which led to weakened carotenoid synthesis. The improved flux that was originally involved in CoQ(10) production and phytoene synthesis was redirected toward FOH synthesis via metabolic modification. This is the first reported instance of FOH and CoQ(10) co-production in R. sphaeroides using a metabolic engineering strategy. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12934-019-1145-6) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6544981 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-65449812019-06-04 Co-production of farnesol and coenzyme Q(10) from metabolically engineered Rhodobacter sphaeroides Chen, Xueduan Jiang, Xianzhang Xu, Man Zhang, Mingliang Huang, Runye Huang, Jianzhong Qi, Feng Microb Cell Fact Research BACKGROUND: Farnesol is an acyclic sesquiterpene alcohol present in the essential oils of various plants in nature. It has been reported to be valuable in medical applications, such as alleviation of allergic asthma, gliosis, and edema as well as anti-cancerous and anti-inflammatory effects. Coenzyme Q(10) (CoQ(10)), an essential cofactor in the aerobic respiratory electron transport chain, has attracted growing interest owing to its clinical benefits and important applications in the pharmaceutical, food, and health industries. In this work, co-production of (E,E)-farnesol (FOH) and CoQ(10) was achieved by combining 3 different exogenous terpenes or sesquiterpene synthase with the RNA interference of psy (responsible for phytoene synthesis in Rhodobacter sphaeroides GY-2). RESULTS: FOH production was significantly increased by overexpressing exogenous terpene synthase (TPS), phosphatidylglycerophosphatase B (PgpB), and sesquiterpene synthase (ATPS), as well as RNAi-mediated silencing of psy coding phytoene synthase (PSY) in R. sphaeroides strains. Rs-TPS, Rs-ATPS, and Rs-PgpB respectively produced 68.2%, 43.4%, and 21.9% higher FOH titers than that of the control strain. Interestingly, the CoQ(10) production of these 3 recombinant R. sphaeroides strains was exactly opposite to that of FOH. However, CoQ(10) production was almost unaffected in R. sphaeroides strains modified by psy RNA interference. The highest FOH production of 40.45 mg/L, which was twice as high as that of the control, was obtained from the TPS-PSYi strain, where the exogenous TPS was combined with the weakening of the phytoene synthesis pathway via psy RNA interference. CoQ(10) production in TPS-PSYi, ATPS-PSYi, and PgpB-PSYi was decreased and lower than that of the control strain. CONCLUSIONS: The original flux that contributed to phytoene synthesis was effectively redirected to provide precursors toward FOH or CoQ(10) synthesis via psy RNA interference, which led to weakened carotenoid synthesis. The improved flux that was originally involved in CoQ(10) production and phytoene synthesis was redirected toward FOH synthesis via metabolic modification. This is the first reported instance of FOH and CoQ(10) co-production in R. sphaeroides using a metabolic engineering strategy. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12934-019-1145-6) contains supplementary material, which is available to authorized users. BioMed Central 2019-05-31 /pmc/articles/PMC6544981/ /pubmed/31151455 http://dx.doi.org/10.1186/s12934-019-1145-6 Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Chen, Xueduan Jiang, Xianzhang Xu, Man Zhang, Mingliang Huang, Runye Huang, Jianzhong Qi, Feng Co-production of farnesol and coenzyme Q(10) from metabolically engineered Rhodobacter sphaeroides |
title | Co-production of farnesol and coenzyme Q(10) from metabolically engineered Rhodobacter sphaeroides |
title_full | Co-production of farnesol and coenzyme Q(10) from metabolically engineered Rhodobacter sphaeroides |
title_fullStr | Co-production of farnesol and coenzyme Q(10) from metabolically engineered Rhodobacter sphaeroides |
title_full_unstemmed | Co-production of farnesol and coenzyme Q(10) from metabolically engineered Rhodobacter sphaeroides |
title_short | Co-production of farnesol and coenzyme Q(10) from metabolically engineered Rhodobacter sphaeroides |
title_sort | co-production of farnesol and coenzyme q(10) from metabolically engineered rhodobacter sphaeroides |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6544981/ https://www.ncbi.nlm.nih.gov/pubmed/31151455 http://dx.doi.org/10.1186/s12934-019-1145-6 |
work_keys_str_mv | AT chenxueduan coproductionoffarnesolandcoenzymeq10frommetabolicallyengineeredrhodobactersphaeroides AT jiangxianzhang coproductionoffarnesolandcoenzymeq10frommetabolicallyengineeredrhodobactersphaeroides AT xuman coproductionoffarnesolandcoenzymeq10frommetabolicallyengineeredrhodobactersphaeroides AT zhangmingliang coproductionoffarnesolandcoenzymeq10frommetabolicallyengineeredrhodobactersphaeroides AT huangrunye coproductionoffarnesolandcoenzymeq10frommetabolicallyengineeredrhodobactersphaeroides AT huangjianzhong coproductionoffarnesolandcoenzymeq10frommetabolicallyengineeredrhodobactersphaeroides AT qifeng coproductionoffarnesolandcoenzymeq10frommetabolicallyengineeredrhodobactersphaeroides |